Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.
作者信息
Bertolini Anna, van de Peppel Ivo P, Bodewes Frank A J A, Moshage Han, Fantin Alberto, Farinati Fabio, Fiorotto Romina, Jonker Johan W, Strazzabosco Mario, Verkade Henkjan J, Peserico Giulia
机构信息
Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
出版信息
Hepatology. 2020 Nov;72(5):1864-1872. doi: 10.1002/hep.31480. Epub 2020 Oct 20.
Abstract
摘要
相似文献
1
Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.新型冠状病毒肺炎患者的肝功能异常检查：相关性及潜在发病机制
Hepatology. 2020 Nov;72(5):1864-1872. doi: 10.1002/hep.31480. Epub 2020 Oct 20.
2
Hepatic Injury in Patients With COVID-19.COVID-19 患者的肝损伤。
J Clin Gastroenterol. 2020 Nov/Dec;54(10):841-849. doi: 10.1097/MCG.0000000000001432.
3
Liver injury in COVID-19: What do we know now?新型冠状病毒肺炎中的肝损伤：我们目前了解多少？
Hepatobiliary Pancreat Dis Int. 2020 Oct;19(5):407-408. doi: 10.1016/j.hbpd.2020.07.009. Epub 2020 Jul 23.
4
Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'.编辑介绍：《危险关系。新冠疫情下的心脏》
Eur J Prev Cardiol. 2020 Jul;27(10):1011-1013. doi: 10.1177/2047487320936413.
5
Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.COVID-19 住院非 ICU 患者的临床特征与肝损伤：一项回顾性研究。
Liver Int. 2020 Jun;40(6):1321-1326. doi: 10.1111/liv.14449. Epub 2020 Apr 12.
6
The potential impact of COVID-19-related disruption on tuberculosis burden.新冠疫情相关干扰对结核病负担的潜在影响。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.01718-2020. Print 2020 Aug.
7
Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.新型冠状病毒肺炎患者肝脏相关生物标志物异常及前白蛋白的作用
Saudi J Gastroenterol. 2020 Sep-Oct;26(5):272-278. doi: 10.4103/sjg.SJG_239_20.
8
[Role of the cardiac surgeon in the COVID-19 hospital].[心脏外科医生在新冠疫情医院中的角色]
G Ital Cardiol (Rome). 2020 Jul;21(7):526. doi: 10.1714/3386.33639.
9
COVID-19: Perspectives on the Potential Novel Global Threat.新型冠状病毒肺炎：对潜在的新型全球威胁的见解
Rev Recent Clin Trials. 2020;15(2):84-86. doi: 10.2174/1574887115999200228100745.
10
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?他汀类药物和前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂对家族性高胆固醇血症患者是否具有预防新型冠状病毒肺炎（COVID-19）的作用？
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1068-1069. doi: 10.1016/j.numecd.2020.05.003. Epub 2020 May 13.
引用本文的文献
1
Ferroptosis and mitochondrial ROS are central to SARS-CoV-2-induced hepatocyte death.铁死亡和线粒体活性氧是新冠病毒诱导肝细胞死亡的关键因素。
Front Cell Infect Microbiol. 2025 Aug 11;15:1625928. doi: 10.3389/fcimb.2025.1625928. eCollection 2025.
2
COVID-19 and Its Effects on the Hepatobiliary System: A Literature Review.新型冠状病毒肺炎及其对肝胆系统的影响：文献综述
Cureus. 2025 Mar 7;17(3):e80231. doi: 10.7759/cureus.80231. eCollection 2025 Mar.
3
Altered liver hemodynamics in patients with COVID-19: a cross sectional study.2019冠状病毒病患者肝脏血流动力学改变：一项横断面研究
J Ultrasound. 2025 Apr 2. doi: 10.1007/s40477-025-01012-z.
4
Development and validation of a nomogram to assess the occurrence of liver dysfunction in patients with COVID-19 pneumonia in the ICU.一种用于评估ICU中新冠肺炎患者肝功能障碍发生情况的列线图的开发与验证
BMC Infect Dis. 2025 Mar 10;25(1):332. doi: 10.1186/s12879-025-10684-1.
5
Pre-infection liver function is associated with all-cause mortality among hemodialysis patients with SARS-CoV-2 Omicron variant infection.感染 SARS-CoV-2 奥密克戎变异株的血液透析患者中，感染前肝功能与全因死亡率相关。
Ren Fail. 2024 Dec;46(2):2425069. doi: 10.1080/0886022X.2024.2425069. Epub 2024 Nov 18.
6
Altered Liver Enzyme Markers in Patients with Asymptomatic, and Mild Omicron Infection: A Retrospective Study.无症状和轻度奥密克戎感染患者肝脏酶标志物的变化：一项回顾性研究
J Inflamm Res. 2024 Sep 30;17:6875-6885. doi: 10.2147/JIR.S478812. eCollection 2024.
7
An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19.天冬氨酸转氨酶升高可预测日本新冠肺炎患者疾病严重程度的恶化。
Clin Pract. 2024 Aug 20;14(4):1601-1614. doi: 10.3390/clinpract14040129.
8
Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management.新型冠状病毒肺炎相关肝损伤的研究进展：病因、诊断与治疗。
Inflammopharmacology. 2024 Oct;32(5):2649-2680. doi: 10.1007/s10787-024-01535-7. Epub 2024 Aug 10.
9
Clinical and Genomic Perspective of SARS CoV-2 Infection in Liver Disease Patients: A Single-Centre Retrospective Study.肝脏疾病患者中严重急性呼吸综合征冠状病毒 2 感染的临床和基因组观点：一项单中心回顾性研究。
Curr Microbiol. 2024 Aug 8;81(9):301. doi: 10.1007/s00284-024-03786-7.
10
Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.新冠疫情在布朗克斯的蒙特菲奥里医疗系统爆发3.5年后新出现的肝脏疾病的发病率、特征及风险因素
PLoS One. 2024 Jun 13;19(6):e0303151. doi: 10.1371/journal.pone.0303151. eCollection 2024.
本文引用的文献
1
The protein expression profile of ACE2 in human tissues.ACE2 在人体组织中的蛋白表达谱。
Mol Syst Biol. 2020 Jul;16(7):e9610. doi: 10.15252/msb.20209610.
2
Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.严重 COVID-19 呼吸衰竭患者的肝脏组织病理学表现提示血管改变。
Liver Int. 2020 Sep;40(9):2110-2116. doi: 10.1111/liv.14601. Epub 2020 Jul 20.
3
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
4
Clinical characteristics of 82 cases of death from COVID-19.COVID-19 死亡 82 例的临床特征。
PLoS One. 2020 Jul 9;15(7):e0235458. doi: 10.1371/journal.pone.0235458. eCollection 2020.
5
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort.新型冠状病毒肺炎相关急性肝损伤：在美国大型队列中的发生率及与临床结局的相关性。
Hepatology. 2020 Sep;72(3):807-817. doi: 10.1002/hep.31404.
6
Liver tests abnormalities in COVID-19: trick or treat?新冠病毒感染中的肝脏检查异常：是陷阱还是机遇？
J Hepatol. 2020 Nov;73(5):1275-1276. doi: 10.1016/j.jhep.2020.05.033. Epub 2020 May 27.
7
Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2.单细胞RNA测序分析未预测到严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对肝细胞的感染。
J Hepatol. 2020 Oct;73(4):993-995. doi: 10.1016/j.jhep.2020.05.030. Epub 2020 May 28.
8
Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City.肥胖与 COVID-19 患者的不良结局相关：来自纽约市早期数据的分析。
Obesity (Silver Spring). 2020 Sep;28(9):1606-1612. doi: 10.1002/oby.22923.
9
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.瑞德西韦治疗重症 COVID-19 患者的 5 天与 10 天疗程比较
N Engl J Med. 2020 Nov 5;383(19):1827-1837. doi: 10.1056/NEJMoa2015301. Epub 2020 May 27.
10
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.羟氯喹或氯喹治疗或预防 COVID-19：一项实时系统评价。
Ann Intern Med. 2020 Aug 18;173(4):287-296. doi: 10.7326/M20-2496. Epub 2020 May 27.
Zotero 插件